Escolar Documentos
Profissional Documentos
Cultura Documentos
References
1. Duff G. Chairman, Commission of Human Medicines. Safety of selective and non-selective. NSAIDs. Letter. October 2006. Accessed from www.mhra.gov.uk/home/idcplg?IdcService
=GET_FILE&dDocName=CON2025036&RevisionSelectionMethod=Latest on 23/04/08
2. National Prescribing Centre. Cardiovascular and gastrointestinal safety of NSAIDs. MeReC Extra 30. November 2007. Accessed from www.npc.co.uk/MeReC_Extra/2008/no30_2007.html
on 23/04/08
3. Personal communication. NHS Business Service Authority Prescription Pricing Division. April 2008
4. National Institute for Health and Clinical Excellence. Osteoarthritis: the care and management of osteoarthritis in adults. NICE clinical guideline 59. February 2008. Accessed from
www.nice.org.uk/guidance/index.jsp?action=byID&o=11926 on 23/04/08
5. National Prescribing Centre. NICE publishes clinical guidance on management of osteoarthritis. NPCi blog 85. March 2008. Accessed from www.npci.org.uk/blog/?p=85 on 23/04/08
6. The National Collaborating Centre for Chronic Conditions. Osteoarthritis: national clinical guideline for care and management in adults. NICE Full Clinical Guideline 59. Accessed from
www.nice.org.uk/guidance/index.jsp?action=download&o=39720 on 23/04/08
7. Rostom A, Muir K, Dube C, et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane collaboration systematic review. Clin Gastroenterol Hepatol 2007;5:818–28
8. Laine L, Curtis SP, Cryer B, et al. Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib
and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. Lancet 2007;369:465-73
9. Rahme E, Barkun AN, Toubouti Y, et al. Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib? Arthritis Rheum 2007; 57:748–55
10. Abraham NS, Hartman C, Castillo D, et al. Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users. Am J Gastroenterol 2008;103:323–32
The National Institute for Health and Clinical Excellence (NICE) is associated with MeReC Publications published by the NPC through a funding contract. This
arrangement provides NICE with the ability to secure value for money in the use of NHS funds invested in its work and enables it to influence topic selection,
methodology and dissemination practice. NICE considers the work of this organisation to be of value to the NHS in England and Wales and recommends that it
be used to inform decisions on service organisation and delivery. This publication represents the views of the authors and not necessarily those of the Institute.
NPC materials may be downloaded / copied freely by people employed by the NHS in England for purposes that support NHS activities in England.
Any person not employed by the NHS, or who is working for the NHS outside England, who wishes to download / copy NPC materials for purposes other
than their personal use should seek permission first from the NPC. Email: copyright@npc.nhs.uk Copyright 2008
National Prescribing Centre, The Infirmary, 70 Pembroke Place, Liverpool, L69 3GF Tel: 0151 794 8146 Fax: 0151 794 8139 www.npc.co.uk www.npc.nhs.uk